Blood pressure control by drug group in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

WC, Cushman; CE, Ford; PT, Einhorn; JT Jr, Wright; RA, Preston; BR, Davis; JN, Basile; PK, Whelton; RJ, Weiss; A, Bastien; DL, Courtney; BP, Hamilton; K, Kirchner; GT, Louis; TM, Retta; DG, Vidt

doi:10.1111/j.1751-7176.2008.00015.x

Public

Blood pressure control by drug group in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Published in Journal of clinical hypertension (Greenwich, Conn.) • Oct 1, 2008

Authors:

Cushman WC

Ford CE

Einhorn PT

Abstract

Blood pressure (BP) control rates and number of antihypertensive medications were compared (average follow-up, 4.9 years) by randomized groups: chlorthalidone, 12.5-25 mg/d (n=15,255), amlodipine 2.5-10 mg/d (n=9048), or lisinopril 10-40 mg/d (n=9054) in a randomized double-blind hypertension trial....

View

Open Access

Generate AI Take for this paper

Highlights, strengths & weaknesses, commercial applications, and societal impact — written for this paper on demand.

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!